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Layered Xerogel Films Incorporating Monolayer Protected Cluster Networks on Platinum Black
Modified Electrodes for Enhanced Sensitivity in 1 Generation Uric Acid Biosensing
st

Mulugeta B. Wayu, Michael J. Pannell, and Michael C. Leopold*
Department of Chemistry, Gottwald Center for the Sciences, University of Richmond

Richmond, VA 23173
ABSTRACT
Amperometric uric acid (UA) biosensing schemes incorporating networks of alkanethiolateprotected gold nanoparticles, monolayer protected clusters (MPCs), and platinum black (Pt–B)
electrode modification via layer-by-layer construction of xerogels are investigated. MPC doping
and Pt-B augmentation are implemented within hydroxymethyl–triethoxy silane xerogel bilayers
at platinum electrodes. The first xerogel adlayer is doped with an MPC network and houses uricase
for the enzymatic reaction required for 1 generation schemes. Polyluminol-aniline and
polyurethane are used as selective/stabilizing interfacial layers. Sensing performance with and
without Pt–B and/or MPC doping is assessed via amperometry with standardized UA injections.
The use of each individual material results in enhancement of UA sensitivity compared to
analogous films without said materials. The use of Pt–B and MPC doping in concert results in a
biosensor design with the highest observed UA sensitivity (0.97 µA·mM ) and fast, linear
responses over physiologically relevant UA concentrations. Enhancement is attributed to Pt–B
providing increased electrode surface area and integration into the xerogel for greater electronic
coupling of the MPC network and more efficient reporting of H O oxidation. The findings have
implications for advancing clinical in vivo sensing devices that require scalability or additional
biocompatibility layering - both of which would benefit from signal enhancement strategies.
st
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1. Introduction
Biosensor research is gaining more attention due to its numerous applications that span
many different fields. The simplicity and adaptability to different clinically relevant analytes and
industrial applications allow electrochemical sensor research to continue at the forefront of this
developing technology sector. Enzyme–based amperometric biosensors offer effective selectivity
[1]

in the detection of trace amounts of target molecules within complex matrices. In particular, 1
[2]

st

generation amperometric biosensors employ the immobilization of oxidase enzymes which,
catalyze the reaction of molecular oxygen with specific analyte to produce hydrogen peroxide
(H O ) by-product. The H O is subsequently oxidized/reduced at a working electrode surface to
2

2

2

2

yield a current response proportional to analyte concentration. Such biosensors have the advantage
of affordability and simplicity while also allowing for relatively easy modification to a plethora of
target analytes and possibility of miniaturization for in vitro and in vivo clinical applications.

[1–2]

Uric acid (2,6,8–trihydroxypurine, UA), the main end product of purine nucleotide
metabolism, is a critical factor in many medical conditions. Due to its poor solubility, UA exists
in biological fluids such as human blood serum, plasma, urine and saliva as urate anion at
physiological pH. Many diseases such as gout, hyperuricemia, Lesch–Nyhan syndrome, obesity,
diabetes, high cholesterol, high blood pressure, kidney disease and heart disease are linked to
abnormal levels of UA concentration. Elevated levels of UA in the blood of late term, pregnant
[3]

women suggest higher probability of pregnancy–induced hypertension (PIH), a condition that can
lead to a disorder called pre–eclampsia and significant health risks for both mothers and their
babies. Current UA testing requires time–consuming laboratory evaluation of blood/urine during
which the PIH can remain undiagnosed with increasing risk of serious complications. Hence,
effective UA sensors, capable of accurate, fast, and local monitoring at the bedside, are of interest
in being able to detect and predict abnormal conditions.

[3b]

One approach of biosensor design is to employ specific nanomaterials (NMs) into sensing
schemes, taking advantage of their unique properties such as surface area, electronic conductivity,
and the ability to interface with biomolecules.

[2a, 4]

NMs used as part of sensing devices and strategies

have included, among others, carbon nanotubes (CNT) and metallic nanoparticles (NPs) ,
[5]

[6]

including citrate–stabilized gold colloid nanoparticles (NPs).

[2a, 4d, 7]

In some cases, the NMs are

incorporated into a scaffold material modifying an electrode, such as sol–gel or electropolymer,
2
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that also serves to immobilize the enzyme required for 1 generation biosensing schemes. Despite
st

their prominence in the literature,

[4d, 7]

monolayer–protected clusters (MPCs) are under–represented

in this area of work. In 2013, a 1 generation amperometric glucose biosensor featuring a xerogel
st

layer formed from 3–mercaptopropyl trimethoxy silane (3–MPTMS) and embedded with glucose
oxidase (GOx) was presented with MPC doping to create a NP network within the xerogel. The
[2a]

MPC–doped sensor showed an order of magnitude increase in sensitivity, doubled linear range
and 4–fold decrease in response times compared to similar films without MPC doping. A
subsequent report established that the MPC network allowed for a decreased dependence on
diffusion and a fast electron reporting system throughout the film, factors that significantly
enhanced sensitivity.

[1]

While signal enhancement was ultimately achieved, the scheme suffered

from less–than–optimal selectivity in discriminating against common interferents.
Leopold et al. recently developed a robust, functional layer–by–layer (LbL) system for a
high performance, 1 generation amperometric glucose biosensor model. The sensing scheme
st

included platinum (Pt) electrodes modified with GOx–doped and un–doped xerogel bi–layers and
semipermeable membranes – a composite film with a collaborative and effective functionality.

[8]

While this scheme allows for well–defined dynamic/linear ranges, low response times, and
significant discrimination against common interferents, the layering of the films does depress the
sensitivity of the biosensing response. Both schemes, MPC–doped and 4–layer composite films,
have advantages and disadvantages, but it would be ideal to combine the strategies and optimize
both sensitivity and selectivity simultaneously. In this regard, the synergetic effect of modifying
the underlying electrode and introducing a MPC network in such systems has not yet been
explored.
In this work, two materials are explored in terms of their ability to enhance the performance
of a LbL-constructed uric acid biosensing scheme: the incorporation of an MPC network within
the xerogel layer and the electrochemical deposition of a platinum black (Pt-B) layer as a direct
modification of the platinum electrode transducer. As previously mentioned, MPC doping has
already been shown to enhance amperometric responses for glucose biosensors.

[1,2a]

Similarly, Pt–

B, a layer of amorphous clusters of Pt nanoparticles, has been successfully employed to increase
[9]

the effective surface area of microelectrodes in certain biosensing schemes – a strategy resulting
in a boosted current response.

[9–10]

To our knowledge, however, the use of Pt–B in conjunction with
3
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MPC networks to counteract LbL signal depression in biosensing schemes has not yet been
explored.

2. Experimental Section
2.1.

Materials and Instrumentation.
All chemicals were purchased from Sigma–Aldrich unless specifically stated. Hydrothane

AL25–80A polyurethane (HPU) was obtained from AdvanSource Biomaterials. A platinizing
solution (3% chloroplatinic acid in water) was purchased from LabChem (Pittsburgh, PA).
Hydroxymethyl–triethoxy silane (HMTES) was stored in a desiccated glovebox (Plas
Laboratories, Inc.) and eventually transferred using a sealed micro–centrifuge to maintain the dry,
N environment and eventually deposited in a relative humidity (RH)–controlled chamber (Cole–
2

Parmer) holding 50% RH. Ultra–purified water (H O, 18.3 MΩ·cm, Barnstead) was used to prepare
2

all solutions. Uricase enzyme was created in–house using a previously described procedure,

[11]

which is provided in more detail in Supporting Information. An eight–channel potentiostat (CH
Instruments, 1000B) was used to record amperometric current–time (i–t) curves to evaluate the
analytical performance of the sensors, as described below. Electrochemical cells were comprised
of a common Ag/AgCl (saturated KCl) reference electrode, a common platinum wire counter
electrode (Sigma–Aldrich), and modified platinum working electrodes (2 mm diameter, CH
Instruments).
2.2.

MPC Synthesis
Alkanethiolate–based MPCs were synthesized using a variation of the well–established and

widely used Brust reaction.

[2a, 12]

Briefly, aqueous HAuCl was subjected to tetraoctylammonium
4

bromide in toluene in order to transfer the gold from the aqueous portion to the toluene layer. Two
molar equivalents of hexanethiol (C thiol) was added to the separated organic layer, which was
6

then stirred for a minimum of 30 minutes or until a color change from orange/red to translucent
pale yellow solution was observed. The flask was chilled (0ºC) in an ice bath before chilled
aqueous NaBH was added as a reducing agent to produce metallic gold nucleation and growth in
4

the presence of C thiol, observed as a thick black solution of MPCs in the toluene layer. The
6

4
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reaction was allowed to proceed overnight under these conditions before the organic layer was
separated, rotary–evaporated to dryness, precipitated with acetonitrile, and isolated on a medium
porosity glass frit with vacuum filtration and thorough washing with acetonitrile. As in previous
reports, the thiol–to–gold ratio of 2:1 produced MPCs with an average core structure of Au (C )
[2a]

225

6 75

with a TEM–estimated diameter of ~2.0 nm.

2.3.

Pt Black Synthesis
Platinum working electrodes were polished successively with 1.0, 0.3, and 0.05 µm Al O
2

3

powder (Electron Microscopy Sciences) and rinsed thoroughly with H O after each polishing steps.
2

The electrodes were then electrochemically cleaned by cycling in 0.1 M H SO between +1.2 and
2

4

−0.25 V at 0.25 V/s until the characteristic voltammetry of clean platinum surface was observed.
The cleaned platinum working electrode was platinized in 3% chloroplatinic acid (v/v in water) by
cycling the potential from +0.6 to −0.35 V (vs Ag/AgCl) at sweep rate of 0.02 V/s using a CH
Instruments 630B potentiostat to obtain platinum black (Pt–B) modified platinum (Pt−B/Pt)
working electrode.

[10]

2.4.

Composite Film Fabrication
For fabrication of the biosensor, two centrifuge tubes, one with 3 mg of uricase (UOx)

dissolved in 100 µL of H O and the other containing 25 µL of silane mixed with 100 µL of
2

tetrahydrofuran (THF) and 7 mg of MPCs, were placed on a vortex mixer for ten minutes in a
humidity controlled chamber. After the 10 min. mixing period, 50 µL of the aqueous UOx solution
was transferred into the other centrifuge tube and mixed for another ten minutes. A 3 µL aliquot
of the final mixture was placed on the electrochemically cleaned platinum electrode, either with
or without the Pt–B treatment. A second sol–gel layer, which was prepared in the same manner
with the exception of containing no MPCs or enzyme, was added on top of the dried layer after 5–
30 minutes of waiting for the first layer to dry. Once both layers were deposited on the electrode
surface, the electrodes were allowed to sit for 48 hours in a 50% RH controlled chamber.
The inner selective layer, 1:10 polyluminol:polyaniline (PL–A) layer, was applied based on a
previously discovered procedure.

[11, 13]

PL–A is known to provide selectivity for UA sensing. The
[11]

5
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xerogel–modified electrode described above (Scheme 1) was immersed in 25 mL stirred solution
of a 5 mM aniline solution and 0.5 mM luminol (saturated) mixture (0.1 M H SO ; N degassed, 20
2

4

2

min.). The layer was electropolymerized while stirring using cyclic voltammetry (CV) at a sweep
rate of 50 mV/s cycling between 0.0 and 1.0 V (vs Ag/AgCl reference electrode) for 12 cycles.
Electrodes were rinsed with water and left to dry (ambient, 10 min.).
As used in other biosensing schemes for UA, a polyurethane semipermeable membrane
was used as the last layer in the sensor design. A 100% HPU was prepared by adding 100 mg of
HPU into a mixture of 2.5 mL of ethanol (EtOH) and 2.5 mL of THF solution and then stir
overnight. Once the electrodes had been sitting for 48 hours, 10 µL of the dissolved polyurethane
was deposited onto the electrode surfaces and allowed to dry for 30 minutes.

2.5.

Film Characterization and Biosensor Performance Evaluation
Prior to testing, fabricated biosensors were soaked in 65.55 mM potassium phosphate

buffer solution (pH = 7.00) for a period of one hour. To stabilize the sensor reading, all biosensors
were subjected to +0.65 V vs Ag/AgCl in 25 mL of PBS for 20 minutes (Note: Additional
pretreatment of 8000 s is necessary for biosensors constructed using MPCs and Pt–B to obtain a
steady state background current). During testing, 50 µL aliquots of 50 mM UA stock solution were
injected at 200 s intervals while stirring (1100 rpm) to obtain stair–step response to successive 100
µM UA increases. As in prior work, slopes of calibration curves (i.e., current response vs. UA
concentration) corresponded to sensitivity while response times (t

) were defined as the time

R–95%

required to reach 95% of the total change in current due to an increase in UA concentration. Each
[2a]

variable (e.g., the effect of MPC doping or the Pt-B effect on sensitivity) was tested with an
individual experiment with multiple electrodes serving as experimental and control experiments,
respectively. Each experiment was also repeated to ensure the observed trends were consistent.
The multi-channel potentiostat allow for a number of variables to be controlled (e.g., film
fabrication, solution conditions, reference electrode changes, injection/pipetting technique,
electrode polishing) while largely isolating the variable to be tested.

6
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3. Results and Discussion
Figure 1 is a general representation of a successful biosensing scheme previously
developed using strategic LbL construction of xerogel and polymer films for glucose and uric acid
detection

[1, 2a, 8]

The basic design comprises four primary layers of electrode modification: (a) an

enzyme–encapsulating xerogel layer; (b) an un-doped xerogel (diffusional layer), (c) an inner
selective electropolymer layer, and (d) a multi–functional adlayer of Hydrothane polyurethane
(HPU). Taken collectively, the use of these layers as a composite film was shown to perform
effectively with extended linear/dynamic rages of detection, adequate sensitivity, fast response
times, and high selectivity. Stable xerogel layers are made via traditional sol–gel chemistry using
[2a]

hydroxymethyl–triethoxy silane (HMTES), a common silane with a hydroxyl functionality at the
R group. This particular sensing scheme represents the initial point for our current study focused
[8]

on identifying and demonstrating modifications that amplify the amperometric signal that has be
previously shown to be dampened with each layer of modification with the model glucose system.

[8]

Signal enhancement is critical to increasing sensitivity for the implementation of the strategy and
materials toward target molecules of clinical relevance, like UA monitoring, for example. The
two strategies explored here include (1) incorporation of a MPC network into the xerogel layer
and (2) modification of the underlying electrode with platinum black (Pt–B) to increase
electroactive surface area.

To our knowledge, however, the incorporation of Pt–B into a

biosensing scheme of this nature is unique. Particularly, the sol–gel is doped with hexanethiolate–
stabilized gold clusters known as MPCs, for its well–established stability and versatility compared
to other colloidal metal nanoparticles.

3.1.

[14]

MPC Network Incorporation – “The MPC Effect”
As previously mentioned, MPC doping of a MPTMS xerogel, a thiol-based sol-gel

structure, has been shown to provide significant signal enhancement in glucose biosensing
schemes of this nature. In preparation of the current study, the same type of enhancement through
[2a]

MPC doping of MPTMS xerogels was established for UA, a different target molecule. Calibration
curves of this system with and without MPC doping, shown in Supporting Information (Fig. SI1), demonstrate a similar MPC enhancement effect for UA. While the enhancement achieved with
incorporating MPCs is easily reproduced, the linearity of the response is not sufficient and
7
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prompted exploration of alternative xerogel material for UA biosensing schemes. Even though
MPCs have not been incorporated into any other type of xerogel, prior development of glucose
xerogel-based biosensors suggested that HMTES xerogels may provide a promising alternative
[8]

scaffolding for the current study. To incorporate MPCs into the first HMTES xerogel layer (Fig.
1, inset), the sol–gel was formed by doping an initial HMTES solution with MPCs as well as UOx.
MPC incorporation into the xerogel was confirmed with TEM and has been well–explained in
prior work.

[2a, 8]

After this initial layer, the other layers were deposited as in previous iterations of

this strategy (Fig. 1). After the construction of the multi-layer film was completed, the analytical
sensing performance of the UOx enzyme–doped and MPC–doped sol–gel biosensors, including
the dynamic/linear range of the amperometric step response and sensitivity, were compared to
analogous systems without MPCs. The systems with MPC–doped xerogels showed a significantly
greater current response toward UA compared to sensors without MPCs (Figure 2) across
physiological relevant UA concentration ranges (0.1 mM – 0.7 mM). As shown in Fig. 2 (inset),
[3c]

the amperometric i-t responses of the respective films translate into highly linear calibration curves
showing two–fold greater sensitivity (i.e., 0.80

(+0.15)

vs. 1.54

(+0.43)

µA·mM ) toward UA when the films
–1

are doped with MPCs. This representative result was repeatable and additional examples of the
effect of MPC incorporation into the HMTES xerogel system are included in Supporting
Information (Fig. SI-2-3). The increase in sensitivity is attributed to the MPC network providing
more efficient electronic pathways for reporting the peroxide oxidation throughout the film. Once
generated by the enzymatic reaction with uric acid, the peroxide oxidation, the indirect signal of
uric acid presence in 1 generation biosensing schemes, occurs at the MPC network, decreasing
st

the system’s diffusional dependence.

[1, 2a]

The significance of this result is three–fold in the context of the current study. While the
enhancement of an amperometric signal via the employment of a MPC network has been
previously observed, it has only been reported for a glucose sensing model system. With its
[2a]

successful incorporation into a UA biosensing scheme, these results represent the first translation
of the strategy to a new, clinically relevant target.

Secondly, signal enhancement via the

introduction of a MPC network within the xerogel was previously generated only for a single layer
xerogel system (i.e., Pt modified with MPC–doped MPTMS and PU) whereas this work represents
the first time the MPC–doped xerogel is used in conjunction with an additional, un-doped,
diffusional xerogel layer (Fig. 1) – the xerogel bi–layer system which was so effective in model
8
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glucose sensing systems.

[2a, 8]

Finally, in a prior study, MPCs have only been incorporated into
[2a]

xerogels formed from thiol–functionalized silanes (e.g., MPTMS), making this result the first time
they have been utilized in other types of silane scaffolds. As in our prior work,

[1]

the signal

enhancement induced with the MPC network is attributed to a decreased dependence of peroxide
diffusion and heightened efficiency of reporting of peroxide oxidation throughout the film.

3.2.

Platinum Black Modification – “The Pt–B Effect”
Platinized Pt electrodes have been previously employed to facilitate amperometric and

voltammetric sensors with enhanced current response. Modification of platinum electrodes with
[15]

Pt–B was achieved with performing cyclic voltammetry (CV) of 3% chloroplatinic acid (v/v in
water) via cycling the potential from +0.6 to −0.35 V (vs Ag/AgCl) at scan rate of 0.02 V/s, a
process which visibly coats the electrode surface with a black adlayer. A representative example
of the voltammetry during platinization and pictures of the modified electrodes are provided in
Supporting Information (Fig. SI-4). CV, differential pulse voltammetry (DPV) and
chronocoulometry (CC) of potassium ferricyanide at the modified electrode were used to
determine changes to the electroactive surface upon modification with Pt–B. CV was used to
qualitatively demonstrate alteration of the electrode interface while, CC, the measurement of
charge as a function of time, was employed as previously described using the slope of Anson
[16]

[1]

plots and Equation 1:

𝑄 = 2𝑛𝐹𝐴𝐶𝐷+/-𝜋 /+/-𝑡 +/-

(1)

where Q is the charge passed (C), n is the number of electrons transferred, F is Faraday’s constant
(96,500 C/mole), A is the electroactive surface area (cm ), C is potassium ferricyanide
2

concentration (5.00 mM in 0.50 M KCl), D is the diffusion coefficient for potassium ferricyanide
(7.6 x10 cm /s), and t is the time (s). The electroactive surface area calculated from the slope of
–6

2

Anson plots, examples of which are provided in Supporting Information (Fig. SI-5).
Figure 3 shows examples of potassium ferricyanide CV, DPV, and CC at electrodes
modified with varying levels of Pt–B. The cyclic voltammetry shown in Fig. 3A (inset) is that of
a bare Pt electrode (a) compared to Pt electrodes subjected to subsequent Pt–B treatments (b → e).
The results indicate that Pt–B modified electrodes exhibit higher electrochemical activity towards
9
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the redox reaction of potassium ferricyanide with progressively higher peak currents in direct
correlation with increasing Pt–B deposition. Most notably from the CV results, however, is the
increase in capacitive (i.e., charging) current with Pt-B adlayers, a result expected if electrode area
increases. Given the significant levels of charging current in the cyclic voltammetry of the Pt-B
modified electrodes, ferricyanide voltammetry was also assessed with more sensitive pulse
voltammetry (DPV), a technique better able to discriminate Faradaic current from the charging
current background.

Increasing Faradaic current is observed in the DPV scans with each

successive Pt-B treatment (Fig. 3A), though only a modest increase in current is noticed after for
Pt-B exposures beyond the first.
Potassium ferricyanide CC results parallel the voltammetric measurements with increasing
charge passed with each exposure of the electrode to Pt–B (Fig. 3B). The CC results translate
directly to measureable increases in electroactive surface area of the electrodes. A summary of
[16]

the DPV and CC results for Pt–B modified electrodes is shown graphically in Fig. 3C. The results
indicate that the increasing current is likely related to an increase in surface area of the electrode,
as expected with a Pt-B adlayer. A complete summary of measured current values for CV and
DPV, as well as charge passed from CC experiments is provided in Supporting Information (Table
SI–1) – all of which suggest that the Pt-B is increasing electroactive surface area.
Electrodes were modified with Pt–B prior to the deposition of the xerogel bi–layer and
polymer layers (Fig. 1) and directly compared to a control group without a Pt–B underlayer. While
both systems exhibited step responses across the relevant concentration range (Figure 4), Pt–B
modified Pt electrodes exhibited a significant increase in the size and definition of the stepping, a
nearly two–fold increase in sensitivity (1.38

(±0.54)

vs. 0.8

(+0.15)

µA·mM ). This representative result was
–1

repeatable and an additional example of signal enhancement from Pt-B modification of an
electrode is included in Supporting Information (Figs. SI-6). The enhanced sensitivity suggests
that the Pt–B facilitates an increase in electron transfer as compared to Pt electrodes without Pt–
B, effectively increasing the electroactive area of the electrode without expanding its geometric
footprint – an important aspect of developing miniature biosensing devices for in vitro or in vivo
applications. This result is coherent with the aforementioned electrode response to potassium
ferricyanide (Fig. 3). Similar systems were tested with additional layers of Pt-B applied to the
electrode interface. The results of these experiments, the calibration curves included in Supporting
10
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Information (Fig. SI-7) consistently show that first exposure of Pt-B results in the greatest increase
in sensitivity whereas additional layers of Pt-B seem to decrease the sensitivity and show higher
film-to-film variability. The reasons for these trends are not entirely understood but may be related
to an inherent instability of Pt–B coatings,

[17]

in particular the frailty such material when additional

adlayers are physically deposited on top of it.

3.3.

Platinum Black and MPC Networks – “The Synergetic Effect”
With the effective demonstration of two different strategies that significantly enhance the

sensitivity of the biosensing scheme, MPC–doping and application of a Pt–B underlayer, the two
effects were combined in order to test for a beneficial synergetic effect. Pt–B was applied to
electrodes before deposition of a HMTES xerogel bi–layer where the first layer was doped with
MPCs and a capping layer of 100% HPU. Upon subjection of these films to UA injections as
before, the performance of the films with Pt–B and MPC doping showed a striking increase in
sensitivity compared to systems without these two factors, a nearly 3–fold increase in sensitivity
(2.06 vs. 0.8
+0.48

(+0.15)

µA·mM ). Figure 5 displays the comparison of typical amperometric i-t and
–1

calibration curves for each type of composite film: xerogel only (control), MPC-doped xerogel,
Pt-B modified electrode, and the combination of incorporating MPCs into xerogels at a Pt-B
modified electrode. The sensitivity of using both materials in concert is higher (2.06 µA·mM )
–1

+0.48

than composite films featuring solely MPC doping or Pt-B modification, 1.54
1.38

(±0.54)

µA·mM and
–1

(+0.43)

µA·mM , respectively. A direct comparison of the film employing both of the materials
–1

simultaneously with a film that uses neither material is provided in Supporting Information (Figure
SI-8). This representative result was repeatable and an additional example of the synergetic signal
enhancement from Pt-B modification of an electrode coupled with MPC-doping enhancement is
included in Supporting Information (Figs. SI-9). The combined strategy exhibits increased
sensitivity across the clinically relevant range of UA and should serve to enhance signal within
[3c]

schemes that use layering of materials for selectivity or stability at the expense of dampening
transducer signal. The results suggest that the observed enhancement can be attributed to a
combination of increasing the electroactive surface area which, in turn, may electronically couple
more reporting pathways through the MPC network to the electrode interface.
3.4.

Optimized LbL Uric Acid Biosensor – Full System
11
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In order to complete a functional uric acid biosensor, a semipermeable selective membrane
composed of a polyluminol–aniline (PL–A) electropolymer is added after the xerogel bi–layer and
before the HPU capping layer (see Figure 1). Prior work has established that this
electropolymerized layer is effective at increasing selectivity to uric acid via discrimination of
common interferents. The PL–A layer, however, is another physical layer that dampens the
[11]

current response of the composite film and represents yet another justification for employing the
signal enhancing supplemental materials of the MPC network and Pt–B layer. UA calibration
curves and UA induced current signal are traced as a function of each adlayer and are provided in
Supporting Information (Fig. SI-10) to show the depression of signal that accompanies the addition
of each adlayer. The performance of the full uric acid biosensing system, formed with all four
functional layers as well as Pt–B and the MPC network, is shown in Figure 6 including a
representative i-t curve and a typical calibration curve (Figure 6A). From this data, the sensitivity
of the biosensor can be reported as 0.97 (± 0.11) µA·mM with an effective linear range up to 0.8
–1

mM UA, easily spanning the normal and abnormal (i.e., diagnostic) physiologically relevant range
for UA.

[3c]

The sensor exhibits a typical response time (t

), a conservative estimate of response

R–95%

time allowing for 95% of the total current change to be achieved,

[2a]

of ≤15 seconds. The IUPAC

defined (3σ /β ) working limit of detection of the sensor is 0.015 mM, an order of magnitude
blank

1

below normal physiological levels of UA. The sensitivity and response time are generally stable
for at least 5 days as well (Supporting Information, Fig. SI-11).
An assessment of the selectivity of the full biosensing scheme (Figure 1) is shown in
Figure 6B where a complete film is subjected to injections of common interferents as well as UA
injections of different concentrations. Injections of most interfering species (e.g., ascorbic acid,
oxalic acid, glucose) resulted in insignificant current responses from the sensor relative to the
observed UA response. Some interferents (e.g., acetaminophen and sodium nitrite) resulted in
small responses that were still was significantly smaller than that of UA. Additionally, after
exposure to interferents, the sensor maintained sensitivity to UA concentration with successive
injections of UA at 100 μM and a proportional response to a 300 μM increase (Fig. 6B).
As in certain glucose biosensing reports, selectivity can be compared more quantitatively
with the use of selectivity coefficients comparing the response of an interferent to that of the target
species.

2a,8,10,20

While this approach is rarely included in literature reports, we have utilized the same
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quantitative analysis (equations included in Supporting Information, Table SI-2) to calculate
selectivity coefficients for each interferent and uric acid (300 μM), a result visually presented in
Fig. 6B (inset). The figure emphasizes critical selectivity with a selectivity coefficient of 0.16 for
UA compared to just 0.04 for sodium nitrite and negative selectivity coefficients for ascorbic acid,
oxalic acid, and glucose. A direct comparison of selectivity coefficient values from this study are
compared with glucose biosensing studies known to use the same parameter to establish selectivity
in Supporting Information Table SI-2.

With the exception of acetaminophen (see below)

selectivity coefficient values for this UA sensing scheme are in line with selectivity deemed
effective for other reported glucose biosensing schemes.

18

As with many other UA sensors,

[19]

acetaminophen, with a selectivity coefficient of 0.14, remains a problematic species during
sensing, though we note its selectivity coefficient is lower here than in most studies. Because
acetaminophen is an artificial interferent (i.e., not naturally occurring in the body) it can be
managed with time and patient history to maintain the applicability of the sensing scheme for
medical diagnosis.

[11]

4. Conclusion
As the exploring of advantages and disadvantages of incorporating nanomaterials,
including metallic NPs,

[4c, 4d]

[1–2]

into LbL biosensor schemes increases in the scientific society, it is

crucial to investigate signal enhancement. The use of modified electrodes is prominent in this field
as is the inevitable signal depression that comes from blocking an electrochemical interface with
any foreign material. This study has established two signal–enhancing strategies: the incorporation
of an MPC network and the modification of the electrode interface with Pt–B. Both of these
strategies, either individually or in concert with each other, allowed for an enhance signal for UA
biosensing. The results suggest that the increased electrode surface area achieved with Pt-B
coupled with the MPC network doped into the xerogel layer that also housing the enzymatic
reaction allows for an optimized sensing mechanism where peroxide oxidation is readily reported
via highly efficient electronic communication throughout the film.

[1]

The performance of the complete biosensing scheme presented in this report rivals or
exceeds that of existing UA sensing strategies, a comparison that can be found elsewhere.

[11, 19]

The

significance of the presented findings however, are believed to be more expansive than simply
13
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presenting another UA sensing scheme. First, this work represents the successful demonstration
of using MPC networks from simple model glucose systems

[2a]

to other target species of clinical

relevance, in this case UA for PIH detection and pre–eclampsia risk assessment. The results of
these studies suggest that similar strategies using the same materials could be applied to numerous
other target species and sensor development. Second, in terms of potential in vivo and in vitro
sensors, the proposed sensing scheme demonstrates critical signal enhancing strategies that lend
themselves to miniaturization of the system on to needle or wire microelectrodes. Similarly, with
any implantable device, biocompatibility must be addressed and often is with additional electrode
modification. Whether this modification involves NO releasing materials, polymeric films,
[20]

[21]

or

self–assembled materials, the strategies presented in this study should prove useful for enhancing
[22]

the analytical signal and moving biosensing technology forward.
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Captions (also listed under figures)
Figure 1. Schematic LbL representation of 1 generation UA biosensing scheme featuring
platinum black modification of electrode and xerogel doping with MPCs (Inset).
st

Figure 2. Representative amperometric i-t curves and corresponding calibration curves (Inset)
during successive 0.1 mM injections of uric acid at platinum electrodes modified with (a) UOx
embedded HMTES xerogel and (b) UOx embedded HMTES xerogel doped with MPCs, each
coated with undoped xerogel followed by HPU. Note: In some cases, standard error bars are
smaller than markers for average value (n = 3-4).

Figure 3. (A) Differential pulse voltammetry (anodic sweep),cyclic voltammetry (inset), and (B)
chronocoulometry (CC) of 5 mM potassium ferricyanide (0.5 M KCl) at (a) bare and platinum
black modified platinum electrodes formed from (b-e) 1 to 4 voltammetric deposition scans; (C)
summary of DPV current (n = 4) and CC-determined area (n = 8) as a function of the number of
scans/layers of platinum black. Note: In some cases, standard error bars are smaller than markers
for average value.

Figure 4. Representative amperometric i-t curves and corresponding calibration curves (Inset)
during successive 0.1 mM injections of uric acid at platinum electrodes modified with (a) UOx
embedded HMTES xerogel and (b) Pt–B and UOx embedded HMTES xerogel, each coated with
undoped xerogel followed by HPU. Note: In some cases, standard error bars are smaller than
markers for average value (n = 4).

Figure 5. Representative amperometric i-t curves and corresponding calibration curves (Inset)
during successive 0.1 mM injections of uric acid at platinum electrodes modified with (a) UOx
embedded HMTES xerogel, (b) UOx embedded HMTES xerogel doped with MPCs, (c) Pt–B and
UOx embedded HMTES xerogel, and (d) Pt–B and UOx embedded HMTES xerogel doped with
MPCs, each coated with undoped xerogel followed by HPU. Note: In some cases, standard error
bars are smaller than markers for average value (n=3-4).

Figure 6. (A) Representative amperometric i-t curves and corresponding calibration curve (Inset)
during successive 0.1 mM injections of uric acid at platinum electrodes modified Pt–B, UOx
embedded HMTES xerogel doped with MPCs, undoped HMTES xerogel and 100% HPU; (B)
typical amperometric i-t curve during injections of common interferent species and UA and a
graphical summary (Inset) of selectivity coefficients for acetaminophen (AP), ascorbic acid (AA),
NaNO , and glucose (Glu). Note: In some cases, standard error bars are smaller than markers for
average value (n=4).
2

17

